The Role of Patient-Reported Outcome Clinical Trials & Treatment

October 6, 2016

Pharm Exec convened a roundtable discussion during the 2016 American Society of Clinical Oncology Annual meeting to examine a central question in cancer treatment today: what is the appropriate role of patient-reported outcome (PRO) measures in driving a drug evaluation model that incorporates insights from the real-life patient experience?